The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise
Open accessAbstract
Data suggest that cytokines released during the inflammatory response target subcortical structures including the basal ganglia as well as dopamine function to acutely induce behavioral changes that support fighting infection and wound healing. However, chronic inflammation and exposure to inflammatory cytokines appears to lead to persisting alterations in the basal ganglia and dopamine function reflected by anhedonia, fatigue, and psychomotor slowing. Moreover, reduced neural responses to hedonic reward, decreased dopamine metabolites in the cerebrospinal fluid and increased presynaptic dopamine uptake and decreased turnover have been described. This multiplicity of changes in the basal ganglia and dopamine function suggest fundamental effects of inflammatory cytokines on dopamine synthesis, packaging, release and/or reuptake, which may sabotage and circumvent the efficacy of current treatment approaches. Thus, examination of the mechanisms by which cytokines alter the basal ganglia and dopamine function will yield novel insights into the treatment of cytokine-induced behavioral changes and inflammatory malaise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Self-citationSystemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“Indeed, acute and chronic (2 weeks) administration of high dose LPS (5 mg/kg) to adult mice produced ~50–70% decrease in dopaminergic neurons in the substantia nigra, thought to be mediated in part by the LPS-induced production of TNF-alpha and related increases in oxidative stress [67, 162].”
BackgroundExtrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645 · cited 1×
“Once in the CNS, peripheral inflammatory cytokines or activated immune cells can dramatically influence the tone of local inflammatory networks and propagate neuroinflammation by activating local production of cytokines [84, 104, 171] and inflammatory signaling pathways, such as nuclear factor (NF)-kappaB, janus kinas…”
BackgroundKynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Twenty years of research on cytokine-induced sickness behavior
Dantzer, R., & Kelley, K. W. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.09.006 · Cited by 1,420
Astrocyte Control of Synaptic Transmission and Neurovascular Coupling
Haydon, P. G., & Carmignoto, G. (2006) · Physiological Reviews · doi:10.1152/physrev.00049.2005 · Cited by 1,323
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · cited 3×
“Although early hypotheses regarding IDO and depression were focused on the consequence of tryptophan depletion on serotonin synthesis, more recent data indicate that kynurenine administration alone is sufficient to induce depressive-like behavior in laboratory animals [151].”
Backgroundp38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Self-citationParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 1×
“Depending on the dose, up to 50% of patients administered IFN-alpha as treatment for HCV or malignant melanoma meet symptom criteria for major depression, and up to 80% experience significant fatigue [27, 28, 31, 50, 145, 163, 164, 167].”
BackgroundSelf-citationLiu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000 · cited 3×
“There has been increasing recognition that inflammatory cytokines play an important role in neuronal integrity and can exert profound effects on neurocircuitry and neurotransmitter systems in the brain, ultimately affecting behavior [86, 137, 222].”
BackgroundSelf-citationCytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999 · cited 1×
“Once in the CNS, peripheral inflammatory cytokines or activated immune cells can dramatically influence the tone of local inflammatory networks and propagate neuroinflammation by activating local production of cytokines [84, 104, 171] and inflammatory signaling pathways, such as nuclear factor (NF)-kappaB, janus kinas…”
BackgroundCapuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797
Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.-G., & Bogerts, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.013 · Cited by 791
Lieberman, A. P., Pitha, P. M., Shin, H. S., & Shin, M. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6348 · Cited by 783
Passage of cytokines across the blood–brain barrier
Banks, W. A., Kastin, A. J., & Broadwell, R. D. (1996) · Neuroimmunomodulation · doi:10.1159/000097202 · Cited by 778
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 761
Interleukin-1 Immunoreactive Innervation of the Human Hypothalamus
Breder, C. D., Dinarello, C. A., & Saper, C. B. (1988) · Science · doi:10.1126/science.3258444 · Cited by 758
Neuropsychopharmacology : The Fifth Generation of Progress
Davis, K. L., Charney, D. S., Coyle, J. T., & Nemeroff, C. B. (2002) · Lippincott Williams & Wilkins eBooks · Cited by 747
Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Superoxide Generation from Endothelial Nitric-oxide Synthase
Xia, Y., Tsai, A.-L., Berka, V., & Zweier, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25804 · Cited by 705
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
aan het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., & Mathew, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.038 · Cited by 690
Gao, H., Jiang, J., Wilson, B., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 687
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Jang, S.-W., Liu, X., Yepes, M., Shepherd, K. R., Miller, G. W., Liu, Y., Wilson, W. D., Xiao, G., Blanchi, B., Sun, Y. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913572107 · Cited by 686
Ericsson, A., Kovacs, K., & Sawchenko, P. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-02-00897.1994 · Cited by 683
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
Microglia in health and disease
Kim, S. U., & de Vellis, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20562 · Cited by 663
Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630
Self-citationMajor Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Chung, I. Y., & Benveniste, E. N. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.8.2999 · Cited by 609
Increased Levels of Glutamate in Brains from Patients with Mood Disorders
Hashimoto, K., Sawa, A., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.017 · Cited by 609
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7805 · Cited by 608
Self-citationPrice, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600 · cited 1×
“It is important to note that administration of glutamate receptor antagonists, such as the NMDA antagonist, ketamine, have potent antidepressant effects especially in treatment resistant depressed patients who, as mentioned previously, have been shown to exhibit increased inflammation [1, 160].”
BackgroundInflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Eisenberger, N. I., Berkman, E. T., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.010 · Cited by 596
Cytokines and psychopathology: Lessons from interferon-α
Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562 · cited 2×
“In addition to depression and fatigue, symptoms of insomnia, psychomotor slowing, and cognitive impairment are common in IFN-alpha-treated patients [29, 30].”
Self-citationManipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
Schwarcz, R., & Pellicciari, R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556
Zhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549
Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors
Bower, J. E., Ganz, P. A., Aziz, N., & Fahey, J. L. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200207000-00010 · Cited by 540
The blood-brain barrier and immune function and dysfunction
Banks, W. A., & Erickson, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.031 · Cited by 523
Watkins, L. R., Goehler, L. E., Relton, J. K., Tartaglia, N., Silbert, L., Martin, D., & Maier, S. F. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11105-r · Cited by 516
Invited Review Free radicals and the pathobiology of brain dopamine systems
Cadet, J. L., & Brannock, C. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00031-4 · Cited by 499
Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 13×
“Similar correlations have been observed between reduced CSF HVA and physical fatigue in IFN-alpha-treated humans (r=−0.38, p 0.05, n=29) (Fig 1B) and CSF HVA and neurocognitive decline in patients infected with human immunodeficiency virus (HIV) [48].”
BackgroundInfluentialInterferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Self-citationNeuropsychiatric Adverse Effects of Interferon-??: Recognition and Management
Raison, C. L., Demetrashvili, M., Capuron, L., & Miller, A. H. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00002 · Cited by 483
Self-citationCytokines as mediators of depression: what can we learn from animal studies?
Dunn, A. J., Swiergiel, A. H., & Beaurepaire, R. D. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.023 · Cited by 459
The methylation, neurotransmitter, and antioxidant connections between folate and depression.
Miller, A. L. (2008) · PubMed · Cited by 457
Self-citationThe metabolic topography of parkinsonism
Eidelberg, D., Moeller, J. R., Dhawan, V., Spetsieris, P., Takikawa, S., Ishikawa, T., Chaly, T., Robeson, W., Margouleff, D., Przedborski, S., et al. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.99 · Cited by 455
Kinetics of Neutral Amino Acid Transport Across the Blood‐Brain Barrier
Smith, Q. R., Momma, S., Aoyagi, M., & Rapoport, S. I. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb01039.x · Cited by 454
LaVoie, M. J., & Hastings, T. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01484.1999 · Cited by 447
Rammohan, K. W. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.179 · Cited by 442
Frenois, F., Moreau, M., O’Connor, J., Lawson, M., Micon, C., Lestage, J., Kelley, K. W., Dantzer, R., & Castanon, N. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.03.005 · Cited by 438 · cited 1×
“The observation that locomotor activity and food/water intake recover in a matter of hours, while anhedonic and depressive-like behaviors such as decreased sucrose consumption and immobility in the forced swim test persist for 24 to 48 hours following lipopolysaccharide (LPS) administration [64, 152], has sparked rece…”
BackgroundBonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437
Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed
Dinarello, C. A. (2004) · Journal of Endotoxin Research · doi:10.1179/096805104225006129 · Cited by 435
Chen, Z., Jalabi, W., Shpargel, K. B., Farabaugh, K. T., Dutta, R., Yin, X., Kidd, G. J., Bergmann, C. C., Stohlman, S. A., & Trapp, B. D. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0730-12.2012 · Cited by 432
Monocyte Chemoattractant Protein-1 Regulation of Blood–Brain Barrier Permeability
Stamatovic, S. M., Shakui, P., Keep, R. F., Moore, B. B., Kunkel, S. L., Van Rooijen, N., & Andjelkovic, A. V. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600055 · Cited by 413
Conti, B. (2004) · Frontiers in Bioscience · doi:10.2741/1341 · Cited by 408
Enhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. S. A., Toone, B. K., Bottiglien, T., Laundy, M., Reynolds, E. H., Carney, M. W. P., Flynn, T. G., & Chanarin, I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91942-4 · Cited by 389
Capuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382
Self-citationBrydon, L., Harrison, N. A., Walker, C., Steptoe, A., & Critchley, H. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.007 · Cited by 381 · cited 7×
“Sissolak G, Hoffbrand AV, Mehta AB, Ganeshaguru K. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colonystimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.”
BackgroundInfluentialNeuroinflammation and regulation of glial glutamate uptake in neurological disorders
Tilleux, S., & Hermans, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21325 · Cited by 381
Capuron, L., Schroecksnadel, S., Féart, C., Aubert, A., Higueret, D., Barberger-Gateau, P., Layé, S., & Fuchs, D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.006 · Cited by 368 · cited 2×
“Moreover, in a recent study of healthy elderly persons with low-grade inflammation, peripheral blood concentrations of phenylalanine, tyrosine, and an increased phenylalanine/ tyrosine ratio were associated with neuropsychiatric symptoms including anhedonia and altered sleep [36], potentially reflecting decreased dopa…”
BackgroundRaison, C. L., Borisov, A. S., Majer, M., Drake, D. F., Pagnoni, G., Woolwine, B. J., Vogt, G. J., Massung, B., & Miller, A. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.010 · Cited by 367 · cited 5×
“Depending on the dose, up to 50% of patients administered IFN-alpha as treatment for HCV or malignant melanoma meet symptom criteria for major depression, and up to 80% experience significant fatigue [27, 28, 31, 50, 145, 163, 164, 167].”
BackgroundInfluentialSelf-citationKrupp, L. B., Coyle, P. K., Doscher, C., Miller, A., Cross, A. H., Jandorf, L., Halper, J., Johnson, B., Morgante, L., & Grimson, R. (1995) · Neurology · doi:10.1212/wnl.45.11.1956 · Cited by 359
Self-citationGilbody, S., Lewis, S., & Lightfoot, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj347 · Cited by 357
Leenders, K. L., Palmer, A. J., Quinn, N., Clark, J. C., Firnau, G., Garnett, E. S., Nahmias, C., Jones, T., & Marsden, C. D. (1986) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.8.853 · Cited by 354
ANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
Effects of cytokines and infections on brain neurochemistry
Dunn, A. J. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.04.002 · Cited by 336
Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus
Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., & Cullen, K. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00655.x · Cited by 330
Glutamate‐mediated glial injury: Mechanisms and clinical importance
Matute, C., Domercq, M., & Sánchez‐Gómez, M. (2006) · Glia · doi:10.1002/glia.20275 · Cited by 330
Morrow, G. R., Hickok, J. T., Roscoe, J. A., Raubertas, R. F., Andrews, P. L. R., Flynn, P. J., Hynes, H. E., Banerjee, T. K., Kirshner, J. J., & King, D. K. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.070 · Cited by 324 · cited 5×
“These data are consistent with findings in patients with advanced cancer undergoing chemotherapy, who also exhibit increased inflammation in association with fatigue that is not responsive to SSRIs [2, 17, 136].”
BackgroundInfluentialTavares, R. G., Tasca, C. I., Santos, C. E. S., Alves, L. B., Porciúncula, L. O., Emanuelli, T., & Souza, D. O. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00133-4 · Cited by 320
Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study
Stankoff, B., Waubant, E., Confavreux, C., Edan, G., Debouverie, M., Rumbach, L., Moreau, T., Pelletier, J., Lubetzki, C., Clanet, M., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000158272.27070.6a · Cited by 318
Zhu, C.-B., Lindler, K. M., Owens, A. W., Daws, L. C., Blakely, R. D., & Hewlett, W. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.116 · Cited by 317
Kim, H. Y., Park, E. J., Joe, E.-H., & Jou, I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6072 · Cited by 313
Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1342 · Cited by 308
Self-citationCytokines, stress and depressive illness: Brain-immune interactions.
Anisman, H., & Merali, Z. (2003) · Annals of Medicine · doi:10.1080/07853890310004075 · Cited by 302
Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction
Raison, C. L., Borisov, A. S., Broadwell, S. D., Capuron, L., Woolwine, B. J., Jacobson, I. M., Nemeroff, C. B., & Miller, A. H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0106 · Cited by 299
Self-citationDunn, A. J. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90522-x · Cited by 297
Papakostas, G. I., Mischoulon, D., Shyu, I., Alpert, J. E., & Fava, M. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09081198 · Cited by 297
O'Connor, J. C., Lawson, M. A., André, C., Briley, E. M., Szegedi, S. S., Lestage, J., Castanon, N., Herkenham, M., Dantzer, R., & Kelley, K. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802722 · Cited by 295
(1994) · PubMed · Cited by 294
Cytokines and Sickness Behavior
DANTZER, R., BLUTHÉ, R., LAYÉ, S., BRET‐DIBAT, J., PARNET, P., & KELLEY, K. W. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09597.x · Cited by 288
Folate, vitamin B12, and homocysteine in major depressive disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.3.426 · Cited by 287 · cited 1×
“Interestingly, low serum folate has been associated with increased risk of depression as well as non-response to antidepressant treatment and an increased likelihood of depression relapse [61, 69, 70, 156, 157].”
BackgroundIllness, Cytokines, and Depression
YIRMIYA, R., POLLAK, Y., MORAG, M., REICHENBERG, A., BARAK, O., AVITSUR, R., SHAVIT, Y., OVADIA, H., WEIDENFELD, J., MORAG, A., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05412.x · Cited by 284
Elmquist, J. K., Breder, C. D., Sherin, J. E., Scammell, T. E., Hickey, W. F., Dewitt, D., & Saper, C. B. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970505)381:2<119::aid-cne1>3.0.co;2-6 · Cited by 283
Lacroix, S., & Rivest, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020452.x · Cited by 280 · cited 1×
“Furthermore, endothelial cells and perivascular macrophages respond to circulating cytokines to induce expression of the prostaglandinproducing enzymes cyclooxygenase-2 (COX-2) and prostaglandin E synthase (PGES) [58, 105, 114].”
BackgroundMaes, M., Lambrechts, J., Bosmans, E., Jacobs, J., Suy, E., Vandervorst, C., De Jonckheere, C., Minner, B., & Raus, J. (1992) · Psychological Medicine · doi:10.1017/s0033291700032712 · Cited by 275
Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Neurauter, G., Schrocksnadel, K., Scholl-Burgi, S., Sperner-Unterweger, B., Schubert, C., Ledochowski, M., & Fuchs, D. (2008) · Current Drug Metabolism · doi:10.2174/138920008785821738 · Cited by 274
Maes, M., Bosmans, E., Suy, E., Vandervorst, C., DeJonckheere, C., & Raus, J. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03163.x · Cited by 268 · cited 1×
“Stimulation of the immune system or the administration of inflammatory cytokines to laboratory animals and humans results in a repertoire of behavioral changes, many of which overlap with those experienced during medical illness and those that have been classically described in depression [45, 124].”
BackgroundMorón, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08480.2003 · Cited by 262
Neuropathology of Early HIV‐1 Infection
Gray, F., Scaravilli, F., Everall, I., Chretien, F., An, S., Boche, D., Adle‐Biassette, H., Wingertsmann, L., Durigon, M., Hurtrel, B., et al. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00775.x · Cited by 262
Miller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
Self-citationKonsman, J. P., Vigues, S., Mackerlova, L., Bristow, A., & Blomqvist, A. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20052 · Cited by 257
Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity
Gilbody, S., Lightfoot, T., & Sheldon, T. (2007) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2006.050385 · Cited by 254
MAPK Signal Transduction Underlying Brain Inflammation and Gliosis as Therapeutic Target
Kaminska, B., Gozdz, A., Zawadzka, M., Ellert‐Miklaszewska, A., & Lipko, M. (2009) · The Anatomical Record · doi:10.1002/ar.21047 · Cited by 246
Shaftel, S. S., Carlson, T. J., Olschowka, J. A., Kyrkanides, S., Matousek, S. B., & O'Banion, M. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1418-07.2007 · Cited by 243
Delivery of interferon-β to the monkey nervous system following intranasal administration
Thorne, R. G., Hanson, L. R., Ross, T. M., Tung, D., & Frey, W. H. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.013 · Cited by 242
Capuron, L., Ravaud, A., Miller, A. H., & Dantzer, R. (2004) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2003.11.004 · Cited by 236
Self-citationCytokines and their receptors in the central nervous system: Physiology, pharmacology, and pathology
Rothwell, N. J., Luheshi, G., & Toulmond, S. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02033-0 · Cited by 233
Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301362 · Cited by 229
Self-citationExpression of The Kynurenine Pathway Enzymes in Human Microglia and Macrophages
Guillemin, G. J., Smith, D. G., Smythe, G. A., Armati, P. J., & Brew, G. J. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_12 · Cited by 229
Zhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228
Potter, M. C., Elmer, G. I., Bergeron, R., Albuquerque, E. X., Guidetti, P., Wu, H.-Q., & Schwarcz, R. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.39 · Cited by 228
Entry of Blood-Borne Cytokines into the Central Nervous System: Effects on Cognitive Processes
Banks, W. A., Farr, S. A., & Morley, J. E. (2002) · Neuroimmunomodulation · doi:10.1159/000071472 · Cited by 228
Behan, W. M. H., McDonald, M., Darlington, L. G., & Stone, T. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702940 · Cited by 225 · cited 10×
“In contrast to QUIN, KA reduces glutamate release, and has been shown to be an antagonist of NMDA and α-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors [198].”
BackgroundInfluentialFujigaki, H., Saito, K., Fujigaki, S., Takemura, M., Sudo, K., Ishiguro, H., & Seishima, M. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj072 · Cited by 222
Katsuura, G., Arimura, A., Koves, K., & Gottschall, P. E. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.1.e163 · Cited by 222
Felger, J. C., Alagbe, O., Hu, F., Mook, D., Freeman, A. A., Sanchez, M. M., Kalin, N. H., Ratti, E., Nemeroff, C. B., & Miller, A. H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.026 · Cited by 214
Self-citationButler, J. M., Case, L. D., Atkins, J., Frizzell, B., Sanders, G., Griffin, P., Lesser, G., McMullen, K., McQuellon, R., Naughton, M., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.05.076 · Cited by 214 · cited 2×
“Nevertheless, classical stimulant medications that increase dopamine release and/or block dopamine reuptake have demonstrated limited efficacy in the treatment of fatigue in cancer patients and patients with other medical disorders associated with inflammation [22, 127, 142].”
BackgroundStone, T. W. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01451-6 · Cited by 211
Cytokines, “depression due to a general medical condition”, and antidepressant drugs
Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., et al. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_16 · Cited by 208
Fabry, Z., Fitzsimmons, K. M., Herlein, J. A., Moninger, T. O., Dobbs, M. B., & Hart, M. N. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90281-3 · Cited by 207
Human leukocyte interferon (HuIFN-α): Potent endorphin-like opioid activity
Blalock, J. E., & Smith, E. M. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91284-5 · Cited by 204
Cao, C., Matsumura, K., Yamagata, K., & Watanabe, Y. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.6.r1712 · Cited by 203
Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
Guillot, T. S., & Miller, G. W. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8059-y · Cited by 201
Modafinil in treatment of fatigue in multiple sclerosis
Zifko, U. A., Rupp, M., Schwarz, S., Zipko, H. T., & Maida, E. M. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0765-6 · Cited by 200
Mechanisms of methamphetamine-induced dopaminergic neurotoxicity
Riddle, E. L., Fleckenstein, A. E., & Hanson, G. R. (2006) · The AAPS Journal · doi:10.1007/bf02854914 · Cited by 199
Mar Fan, H. G., Clemons, M., Xu, W., Chemerynsky, I., Breunis, H., Braganza, S., & Tannock, I. F. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0341-9 · Cited by 198
Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain
Schöbitz, B., Voorhuis, D. A. M., & De Kloet, E. R. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90046-a · Cited by 198
Dumitrescu, C., Biondi, R., Xia, Y., Cardounel, A. J., Druhan, L. J., Ambrosio, G., & Zweier, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702986104 · Cited by 192
Amantadine for fatigue in multiple sclerosis
Pucci, E., Brañas Tato, P., D'Amico, R., Giuliani, G., Solari, A., & Taus, C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002818.pub2 · Cited by 187
Weiss, J. M., Downie, S. A., Lyman, W. D., & Berman, J. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6896 · Cited by 186
Anhedonic and Anxiogenic Effects of Cytokine Exposure
Anisman, H., & Merali, Z. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_12 · Cited by 185
Monk, J. P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L. J., Otterson, G. A., Guttridge, D., Rhoades, C., Shah, M., Criswell, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2838 · Cited by 179 · cited 1×
“Indeed, administration of the TNF-alpha antagonist, etanercept, has been shown to inhibit fatigue in patients with advanced cancer [141].”
BackgroundMoraska, A. R., Sood, A., Dakhil, S. R., Sloan, J. A., Barton, D., Atherton, P. J., Suh, J. J., Griffin, P. C., Johnson, D. B., Ali, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1444 · Cited by 175
Glutamate and ATP signalling in white matter pathology
Matute, C. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2010.01339.x · Cited by 172
Lestage, J., Verrier, D., Palin, K., & Dantzer, R. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00014-4 · Cited by 170 · cited 1×
“In the brain, IDO is significantly increased at 24 hr and peaks at 48 hr in response to LPS administration, corresponding to the expression of depressive-like behaviors [117, 151].”
BackgroundHeyes, M. P., Saito, K., Major, E. O., Milstien, S., Markey, S. P., & Vickers, J. H. (1993) · Brain · doi:10.1093/brain/116.6.1425 · Cited by 170
Functional neuroanatomy of the basal ganglia in Parkinson's disease.
Wichmann, T., & DeLong, M. R. (2003) · PubMed · Cited by 169
Kynurenic acid leads, dopamine follows: A new case of volume transmission in the brain?
Wu, H., Rassoulpour, A., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0562-y · Cited by 166
Capuron, L., Fornwalt, F. B., Knight, B. T., Harvey, P. D., Ninan, P. T., & Miller, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.017 · Cited by 164
Self-citationRational Design of Indoleamine 2,3-Dioxygenase Inhibitors
Röhrig, U. F., Awad, L., Grosdidier, A., Larrieu, P., Stroobant, V., Colau, D., Cerundolo, V., Simpson, A. J. G., Vogel, P., Van den Eynde, B. J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9014718 · Cited by 163
Kitagami, T., Yamada, K., Miura, H., Hashimoto, R., Nabeshima, T., & Ohta, T. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02776-8 · Cited by 163
Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain
Shuto, H., Kataoka, Y., Horikawa, T., Fujihara, N., & Oishi, R. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01371-6 · Cited by 151
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149
Quinolinic Acid Production by Macrophages Stimulated with IFN-γ, TNF-α, and IFN-α
PEMBERTON, L. A., KERR, S. J., SMYTHE, G., & BREW, B. J. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.589 · Cited by 149
Kaasinen, V. (2001) · Brain · doi:10.1093/brain/124.6.1125 · Cited by 149
PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
Kumakura, Y., & Cumming, P. D. (2009) · The Neuroscientist · doi:10.1177/1073858409338217 · Cited by 146
NEUROIMMUNOMODULATION VIA LIMBIC STRUCTURES — THE NEUROANATOMY OF PSYCHOIMMUNOLOGY
Haas, H. S., & Schauenstein, K. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00055-x · Cited by 143
Tedeschi, B., Barrett, J. N., & Keane, R. W. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.102.6.2244 · Cited by 141
Guillemin, G. J., Wang, L. H.-C., & Brew, B. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-16 · Cited by 140
Mentis, M. J., McIntosh, A. R., Perrine, K., Dhawan, V., Berlin, B., Feigin, A., Edwards, C., Mattis, P., & Eidelberg, D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.746 · Cited by 136
Ferris, M. J., Mactutus, C. F., & Booze, R. M. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.01.004 · Cited by 135
Treatment of cytokine-induced depression
Capuron, L., Hauser, P., Hinze-Selch, D., Miller, A. H., & Neveu, P. J. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00007-7 · Cited by 132
Masilamoni, G. J., Bogenpohl, J. W., Alagille, D., Delevich, K. M., Tamagnan, G. D., Votaw, J. R., Wichmann, T., & Smith, Y. (2011) · Brain · doi:10.1093/brain/awr137 · Cited by 126
Majer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.009 · Cited by 124
Self-citationKomaki, G., Arimura, A., & Köves, K. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.2.e246 · Cited by 124
(1998) · PubMed · Cited by 121
Nichol, C. A., Lee, C. L., EDELSTEIN, M. P., Chao, J. Y., & Duch, D. S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.6.1546 · Cited by 120
Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography Study
Urban, N., Slifstein, M., Thompson, J. L., Xu, X., Girgis, R. R., Raheja, S., Haney, M., & Abi‐Dargham, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.018 · Cited by 120
Aromatic L‐Amino Acid Decarboxylase Activity of Mouse Striatum Is Modulated via Dopamine Receptors
Hadjiconstantinou, M., Wemlinger, T. A., Sylvia, C.-H., Hubble, J. P., & Neff, N. H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03503.x · Cited by 118
Raison, C. L., Rye, D. B., Woolwine, B. J., Vogt, G. J., Bautista, B. M., Spivey, J. R., & Miller, A. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.019 · Cited by 116
Self-citationPapakostas, G. I., Petersen, T., Mischoulon, D., Ryan, J. L., Nierenberg, A. A., Bottiglieri, T., Rosenbaum, J. F., Alpert, J. E., & Fava, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0810 · Cited by 113
Systemic interferon-α regulates interferon-stimulated genes in the central nervous system
Wang, J., Campbell, I. L., & Zhang, H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002013 · Cited by 108
Ida, T., Hara, M., Nakamura, Y., Kozaki, S., Tsunoda, S., & Ihara, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.047 · Cited by 107
Akiyama, H., Ikeda, K., Katoh, M., McGeer, E. G., & McGeer, P. L. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90046-9 · Cited by 107
Signaling the brain in inflammation: the role of endothelial cells
Matsumura, K., & Kobayashi, S. (2004) · Frontiers in bioscience · doi:10.2741/1439 · Cited by 106
Kamata, M. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00067-x · Cited by 105
Immunobiology of the blood-brain barrier
Miller, D. W. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909021286 · Cited by 104
Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration
Smith, R. A., Norris, F. H., Palmer, D., Bernhardt, L., & Wills, R. J. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.16 · Cited by 103
Enhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. M., Crellin, R. F., Toone, B., Flynn, T., Carney, M. W. P., Laundy, M., Chanarin, I., Bottiglieri, T., & Reynolds, E. H. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.161.1.126 · Cited by 99
Nadjar, A., Combe, C., Layé, S., Tridon, V., Dantzer, R., Amédée, T., & Parnet, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02097.x · Cited by 94
Fms-Like Tyrosine Kinase 3 Ligand Recruits Plasmacytoid Dendritic Cells to the Brain
Curtin, J. F., King, G. D., Barcia, C., Liu, C., Hubert, F., Guillonneau, C., Josien, R., Anegón, I., Lowenstein, P. R., & Castro, M. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3566 · Cited by 92
Palma, J. P., Kwon, D., Clipstone, N. A., & Kim, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6322-6331.2003 · Cited by 90
Depression in medical illness: The role of the immune system
Yirmiya, R. (2000) · Western Journal of Medicine · doi:10.1136/ewjm.173.5.333 · Cited by 87
Oscillations in the basal ganglia
Wichmann, T., & DeLong, M. R. (1999) · Nature · doi:10.1038/23148 · Cited by 83
Regulation of noradrenergic function by inflammatory cytokines and depolarization
Li, W., Knowlton, D. L., Woodward, W. R., & Habecker, B. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01890.x · Cited by 81
Kynurenic acid antagonists and kynurenine pathway inhibitors
Stone, T. W. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.4.633 · Cited by 79
Yamada, T., Horisberger, M. A., Kawaguchi, N., Moroo, I., & Toyoda, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90560-6 · Cited by 77
Stahl, S. M. (2007) · CNS Spectrums · doi:10.1017/s1092852900015418 · Cited by 74
A Reversible Tracer Analysis Approach to the Study of Effective Dopamine Turnover
Sossi, V., Doudet, D. J., & Holden, J. E. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200104000-00015 · Cited by 72
Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2
Papakostas, G. I., Petersen, T., Mischoulon, D., Green, C. H., Nierenberg, A. A., Bottiglieri, T., Rosenbaum, J. F., Alpert, J. E., & D, M. F. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0811 · Cited by 72
Song, C., Horrobin, D. F., & Leonard, B. E. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-941557 · Cited by 70
Gelman, B. B., Spencer, J. A., Holzer, C. E., & Soukup, V. M. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9030-6 · Cited by 69
Indicators of immune activation in depressed patients
Sluzewska, A. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_4 · Cited by 66
Interactions of Cytokines with the Blood-Brain Barrier: Implications for Feeding
Pan, W., & Kastin, A. J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455332 · Cited by 65
Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study
Sugawara, Y., Akechi, T., Shima, Y., Okuyama, T., Akizuki, N., Nakano, T., & Uchitomi, Y. (2002) · Palliative Medicine · doi:10.1191/0269216302pm547xx · Cited by 64
Guillot, T. S., Richardson, J. R., Wang, M. Z., Li, Y. J., Taylor, T. N., Ciliax, B. J., Zachrisson, O., Mercer, A., & Miller, G. W. (2008) · Neuropeptides · doi:10.1016/j.npep.2008.04.003 · Cited by 64
Burton, B. K., Bausell, H., Katz, R., LaDuca, H., & Sullivan, C. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.06.015 · Cited by 62
In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine
Tavares, R. G., Schmidt, A. P., Abud, J., Tasca, C. I., & Souza, D. O. (2005) · Neurochemical Research · doi:10.1007/s11064-005-2678-0 · Cited by 59
Regulation of microglial function by interferons
Colton, C. A., Yao, J., Keri, J. E., & Gilbert, D. L. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90216-8 · Cited by 58
Methamphetamine toxicity and its implications during HIV-1 infection
Silverstein, P. S., Shah, A. B., Gupte, R., Liu, X., Piepho, R. W., Kumar, S., & Kumar, A. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-011-0043-4 · Cited by 58
Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology
Cunnington, C., & Channon, K. M. (2010) · Heart · doi:10.1136/hrt.2009.180430 · Cited by 58
3-Hydroxykynurenine and Quinolinate: Pathogenic Synergism in Early Grade Huntington’s Disease?
Guidetti, P., & Schwarcz, R. M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_16 · Cited by 57
Acute interferon-α administration modulates sucrose consumption in the rat
Sammut, S., Goodall, G., & Muscat, R. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00051-2 · Cited by 56
Kazumori, H., Ishihara, S., Rumi, M. A. K., Ortega-Cava, C. F., Kadowaki, Y., & Kinoshita, Y. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00269.2003 · Cited by 56
Ginsberg, L. D., Oubré, A., & Daoud, Y. (2011) · PubMed · Cited by 55
Rocco, A. D., Bottiglieri, T., Dorfman, D., Werner, P., Morrison, C., & Simpson, D. M. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200007000-00004 · Cited by 53
Utz, J. R. J., Lorentz, C. P., Markowitz, D., Rudser, K. D., Diethelm-Okita, B., Erickson, D., & Whitley, C. B. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.10.014 · Cited by 48
Kumakura, Y., GJEDDE, A. H., Danielsen, E. H., Christensen, S., & Cumming, P. D. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600202 · Cited by 47
Collins, J. M., Riccardi, R., Trown, P. W., O’Neill, D. L., & Poplack, D. G. (1985) · Cancer Drug Delivery · doi:10.1089/cdd.1985.2.247 · Cited by 44
Constitutive Expression of Interleukin-1beta (IL-1beta) in Rat Oligodendrocytes
Blasi, F., Riccio, M., Brogi, A., Strazza, M., Taddei, L., Romagnoli, S., Luddi, A., D’Angelo, R., Santi, S., Costantino‐Ceccarini, E., et al. (1999) · Biological Chemistry · doi:10.1515/bc.1999.034 · Cited by 43
Effects of reserpine on the social behavior of rhesus monkeys.
Wt, M., Rg, E., Ec, M., Sj, S., & Harlow, H. F. (1971) · PubMed · Cited by 42
Interferon decreases REM latency
Reite, M. L., Laudenslager, M. L., Jones, J. F., Crnic, L. S., & Kaemingk, K. L. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90136-3 · Cited by 41
Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems
Santamaría, A., Flores-Escartín, A., Martínez‐Lazcano, J. C., Osorio, L., Galván‐Arzate, S., Pedraza‐Chaverrí, J., Maldonado, P. D., Medina‐Campos, O. N., Jiménez-Capdeville, M. E., Manjarrez-Marmolejo, J., et al. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00317-4 · Cited by 41
Cited by
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Self-citationNeuroscience of apathy and anhedonia: a transdiagnostic approach
Husain, M., & Roiser, J. P. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0029-9 · Cited by 640
Felger, J. C., Li, Z., Haroon, E., Woolwine, B. J., Jung, M. Y., Hu, X., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.168 · Cited by 620
Self-citationInflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Self-citationImaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 427
Self-citation
Metadata
- Authors
- Felger, J. C., & Miller, A. H.
- Venue
- Frontiers in Neuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 33
- Issue
- 3
- Pages
- 315-327
- ISSN
- 0091-3022 (ISSN-L)
- OpenAlex
- W2069604660
- Cited by
- 391
- References
- 224
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.